| 查看: 1226 | 回复: 28 | ||
| 【奖励】 本帖被评价26次，作者asymmsyn增加金币 24.5 个 | ||
| 当前主题已经存档。 | ||
[资源]
The Art of Drug Synthesis
|
||
|
The Art of Drug Synthesis * Publisher: Wiley-Interscience * Number Of Pages: 276 * Publication Date: 2007-07-09 * Sales Rank: 286635 * ISBN / ASIN: 0471752150 * EAN: 9780471752158 * Binding: Hardcover * Manufacturer: Wiley-Interscience * Studio: Wiley-Interscience * Average Rating: * Total Reviews: Book Description: The Art of Drug Synthesis illustrates how chemistry, biology, pharmacokinetics, and a host of other disciplines come together to produce successful medicines. The authors have compiled a collection of 21 representative categories of drugs, from which they have selected as examples many of the best-selling drugs on the market today. An introduction to each drug is provided, as well as background to the biology, pharmacology, pharmacokinetics, and drug metabolism, followed by a detailed account of the drug synthesis. * Edited by prominent scientists working in drug discovery for Pfizer * Meets the needs of a growing community of researchers in pharmaceutical R&D * Provides a useful guide for practicing pharmaceutical scientists as well as a text for medicinal chemistry students * An excellent follow-up to the very successful first book by these editors, Contemporary Drug Synthesis, but with all new therapeutic categories and drugs discussed. 下载连接地址： http://rapidshare.com/files/56350607/Johns9780471752158.rar |
回复此楼» 猜你喜欢
脑梗怎么治疗
已经有3人回复
-
脑梗怎么治疗
已经有0人回复
-
药物学论文润色/翻译怎么收费?
已经有96人回复
-
如何高效的测量腺病毒的粒径和电位
已经有0人回复
-
生物组织中有目标分析物，专属性怎么做
已经有0人回复
-
[求助] 流式死活染 & 单细胞门控设置被质疑，如何优化并解释？
已经有1人回复
-
蛋白稳定性实验与功能实验不一致
已经有11人回复
-
第4年了，马上40了，可能我与国基确实无缘吧。。。
已经有12人回复
-
2026年申博药学专业
已经有1人回复
-
26在职申博—生物与医药—抗体/ADC药物方向，江浙沪，有项目，可带资。
已经有1人回复
3楼2007-09-18 22:30:59
4楼2007-09-19 09:27:10
6楼2007-09-19 10:44:32
7楼2007-09-19 17:36:36
8楼2007-09-19 19:13:49
9楼2007-09-19 23:20:21
10楼2007-09-20 08:15:21
11楼2007-09-20 09:21:02
13楼2007-09-24 12:50:09
简单回复
2007-09-18 12:19
回复
wjswift5楼
2007-09-19 10:24
回复
谢谢分享！
thetopsky12楼
2007-09-24 10:56
回复
